Mariniello, D.F.; Pagliaro, R.; D’Agnano, V.; Schiattarella, A.; Perrotta, F.; Bianco, A.
Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study. Pharmacy 2025, 13, 65.
https://doi.org/10.3390/pharmacy13030065
AMA Style
Mariniello DF, Pagliaro R, D’Agnano V, Schiattarella A, Perrotta F, Bianco A.
Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study. Pharmacy. 2025; 13(3):65.
https://doi.org/10.3390/pharmacy13030065
Chicago/Turabian Style
Mariniello, Domenica Francesca, Raffaella Pagliaro, Vito D’Agnano, Angela Schiattarella, Fabio Perrotta, and Andrea Bianco.
2025. "Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study" Pharmacy 13, no. 3: 65.
https://doi.org/10.3390/pharmacy13030065
APA Style
Mariniello, D. F., Pagliaro, R., D’Agnano, V., Schiattarella, A., Perrotta, F., & Bianco, A.
(2025). Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study. Pharmacy, 13(3), 65.
https://doi.org/10.3390/pharmacy13030065